EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,065,656 | +70.8% | 250,991 | +50.5% | 0.01% | +60.0% |
Q1 2023 | $1,209,170 | +312.1% | 166,782 | +404.2% | 0.01% | +150.0% |
Q4 2022 | $293,393 | -83.8% | 33,077 | -77.6% | 0.00% | -81.8% |
Q3 2022 | $1,811,000 | +408.7% | 147,929 | +690.7% | 0.01% | +266.7% |
Q1 2022 | $356,000 | -50.0% | 18,708 | -30.2% | 0.00% | -40.0% |
Q4 2021 | $712,000 | -18.8% | 26,811 | +25.6% | 0.01% | -54.5% |
Q3 2021 | $877,000 | +34.9% | 21,341 | +37.8% | 0.01% | +10.0% |
Q1 2021 | $650,000 | +35.4% | 15,486 | -9.5% | 0.01% | +42.9% |
Q3 2020 | $480,000 | -55.0% | 17,108 | -52.5% | 0.01% | -78.8% |
Q4 2019 | $1,066,000 | – | 35,987 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |